United Therapeutics (UTHR) Tops Q3 EPS by 23c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $542.42 +0.77%
EPS Growth %: +12.6%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +12.6%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $5.38, $0.23 better than the analyst estimate of $5.15. Revenue for the quarter came in at $609.4 million versus the consensus estimate of $587.9 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Bristow Group to acquire Berry Aviation for $105 million
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
